Literature DB >> 29056399

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?

Alberico Luigi Catapano1, Angela Pirillo2, Giuseppe Danilo Norata3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29056399      PMCID： PMC5675606          DOI： 10.1016/j.ymthe.2017.10.008

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease.

Authors:  Tomohiko Sakatani; Takeshi Shirayama; Yoko Suzaki; Taku Yamamoto; Hiroki Mani; Tatsuya Kawasaki; Hiroki Sugihara; Hiroaki Matsubara
Journal:  Int Heart J       Date:  2005-07       Impact factor: 1.862

2.  Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.

Authors:  Benjamin M Scirica; David A Morrow; Christopher P Cannon; Kausik K Ray; Marc S Sabatine; Petr Jarolim; Amy Shui; Carolyn H McCabe; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2006-05-04       Impact factor: 24.094

Review 3.  Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.

Authors:  Kumudha Ramasubbu; Jerry Estep; Donna L White; Anita Deswal; Douglas L Mann
Journal:  J Am Coll Cardiol       Date:  2008-01-29       Impact factor: 24.094

Review 4.  Statin therapy improves long-term survival in non-ischaemic cardiomyopathy: a pooled analysis of 4500 patients.

Authors:  Salil V Deo; Abeer Rababa'h; Salah E Altarabsheh; Ju Yong Lim; Yang Hyun Cho; Soon J Park
Journal:  Heart Lung Circ       Date:  2014-04-18       Impact factor: 2.975

5.  Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.

Authors:  T R Pedersen
Journal:  Am J Cardiol       Date:  1998-11-26       Impact factor: 2.778

6.  Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.

Authors:  Ilayaraja Muthuramu; Ruhul Amin; Andrey Postnov; Mudit Mishra; Joseph Pierre Aboumsallem; Tom Dresselaers; Uwe Himmelreich; Paul P Van Veldhoven; Olivier Gheysens; Frank Jacobs; Bart De Geest
Journal:  Mol Ther       Date:  2017-08-01       Impact factor: 11.454

7.  Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.

Authors:  Urban Alehagen; Lina Benson; Magnus Edner; Ulf Dahlström; Lars H Lund
Journal:  Circ Heart Fail       Date:  2015-01-09       Impact factor: 8.790

Review 8.  Long-term clinical outcomes of statin use for chronic heart failure: a meta-analysis of 15 prospective studies.

Authors:  Jian-Qiang Wang; Guo-Rong Wu; Zheng Wang; Xiao-Ping Dai; Xiang-Rong Li
Journal:  Heart Lung Circ       Date:  2013-08-17       Impact factor: 2.975

9.  Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50.

Authors:  Urban Alehagen; Lina Benson; Magnus Edner; Ulf Dahlström; Lars H Lund
Journal:  Circ Heart Fail       Date:  2015-08-04       Impact factor: 8.790

10.  Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Authors:  Jennifer K Rogers; Pardeep S Jhund; Ana-Cristina Perez; Michael Böhm; John G Cleland; Lars Gullestad; John Kjekshus; Dirk J van Veldhuisen; John Wikstrand; Hans Wedel; John J V McMurray; Stuart J Pocock
Journal:  JACC Heart Fail       Date:  2014-04-30       Impact factor: 12.035
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.